In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Oncologic Inc.

Division of Aduro Biotech/Oncologic Inc.

Latest From Oncologic Inc.

Deal Watch: Bristol, Janssen Keep The Heat High In Cancer Immunotherapy Deal-Making

Bristol signs a licensing deal around CytomX’s Probody technology platform and becomes the third firm to set up a combination trial with Incyte’s IDO1 inhibitor. Janssen licenses novel immunotherapy candidates for prostate cancer from Aduro; Oncothyreon and Celldex arrange a combo trial in breast and ovarian cancer.

BioPharmaceutical Deals

Start-Up Previews (9/02)

A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group, Cancer Therapeutics, feature Cyclis Pharmaceuticals Inc., Mojave Therapeutics Inc., OncoGeneX Technologies Inc. and Oncologic Inc. Plus these selected Start-Ups across Health Care: CardiacAssist Inc., PharMetrics Inc., Sleep Solutions Inc. and Xoft microTube Inc.

Oncologic Inc.

Oncologic Inc. hopes to circumvent the heterogeneity of solid tumors with a multi-step process. It will target two independent cellular cancer characteristics-the presence of an endocytosing receptor, and sensitivity to a chemotherapeutic agent; then erect a novel chemical platform throughout the tumor to hold radioactive isotopes in place to kill the entire tumor, not just individual cancer cells.
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Aduro Biotech
  • Senior Management
  • Stephen T Isaacs, Pres. & CEO
    Winston Salser, Chmn.
  • Contact Info
  • Oncologic Inc.
    Phone: (510) 222-3501
    3065 Richmond Pkwy.
    Ste. 117
    Richmond, CA 94806